Epalrestat

Mechanism of Action

Epalrestat functions as an inhibitor of the aldose reductase enzyme, specifically targeting the aldo-keto reductase family 1 member B1 (AKR1B1) in humans. By impeding this enzyme's activity, Epalrestat plays a crucial role in the management of diabetic complications. Aldose reductase is a key enzyme that catalyzes the reduction of glucose to sorbitol, a process that, when excessively activated, is linked to the pathogenesis of various diabetic complications. Through the inhibition of AKR1B1, Epalrestat effectively reduces the accumulation of sorbitol within cells, thereby alleviating osmotic and oxidative stress. This action supports nerve health by mitigating damage often associated with diabetic neuropathy, offering a targeted therapeutic approach for individuals managing diabetes-related conditions.